SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-071454
Filing Date
2023-03-15
Accepted
2023-03-15 17:05:38
Documents
5
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 d477001ds8.htm S-8 44623
2 EX-5.1 d477001dex51.htm EX-5.1 6457
3 EX-23.2 d477001dex232.htm EX-23.2 1714
4 EX-FILING FEES d477001dexfilingfees.htm EX-FILING FEES 21417
5 GRAPHIC g477001g0314094450131.jpg GRAPHIC 2361
  Complete submission text file 0001193125-23-071454.txt   78753
Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270577 | Film No.: 23736061
SIC: 2836 Biological Products, (No Diagnostic Substances)